Pharmabiz13h
Vir Biotech gets US FDA breakthrough therapy designation & EMA PRIME designation for tobevibart, elebsiran to treat chronic hepatitis delta
Vir Biotechnology, Inc, a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and ...
Pharmabiz13h
NIH funded study shows long-term exposure to air pollution linked to blood clots in veins that bring blood to the heart
A large study found that greater exposure to long-term air pollution was linked with increased risks for blood clots that can occur in deep veins, which, if untreated, can block blood flow and cause ...
Pharmabiz19h
Pharmacy career immune to recession, economic downturns; offers diverse job avenues
Pharmacy career is viewed as recession-resistant due to several key factors that contribute to its resilience during economic downturns. The ongoing advancement in pharmaceutical sciences and the ...
Pharmabiz19h
Indian pharma industry set to make a mark at Clinical Pharmacy Congress London 2025
The Indian pharmaceutical industry is set to make a powerful statement on the global stage at the Clinical Pharmacy Congress London (CPCL) 2025, Europe’s largest and most prestigious gathering of ...
Pharmabiz17h
AIIMS signs MoU with Wipro GE Healthcare to establish ‘AI Health Innovations Hub’ to advance precision health solutions for India & the world
AIIMS signs MoU with Wipro GE Healthcare to establish ‘AI Health Innovations Hub’ to advance precision health solutions for India & the world: Our Bureau, Mumbai Saturday, Dec ...
Pharmabiz18h
Roche’s new and updated molecular cobas 6800/8800 systems receives CE certification
Roche’s new and updated molecular cobas 6800/8800 systems receives CE certification: Basel Saturday, December 14, 2024, 15:00 Hrs [IST] Roche announced the CE certification of t ...
Pharmabiz19h
DoP re-opens application window for API CF sub-scheme
The Department of Pharmaceuticals (DoP) has re-opened the application window for the sub-scheme to assist pharma units to set up common facilities, under the scheme for Strengthening of ...
Pharmabiz20h
Bayer initiates phase I study with SOS1 inhibitor, BAY3498264 in patients with advanced KRAS-mutated tumours
Bayer initiates phase I study with SOS1 inhibitor, BAY3498264 in patients with advanced KRAS-mutated tumours: Berlin Saturday, December 14, 2024, 13:00 Hrs [IST] Bayer announced i ...
Pharmabiz10h
US FDA accepts Ascendis’ sBLA of TransCon for review to treat adults with growth hormone deficiency
Ascendis Pharma A/S, a global pharma company applying its innovative TransCon technology platform to build a leading and fully integrated biopharma company focused on making a meaningful difference in ...
Pharmabiz21h
BeiGene enters global licensing agreement CSPC Zhongqi Pharmaceutical for MAT2A inhibitor for solid tumours
BeiGene enters global licensing agreement CSPC Zhongqi Pharmaceutical for MAT2A inhibitor for solid tumours: San Mateo, California Saturday, December 14, 2024, 12:00 Hrs [IST] Bei ...
Pharmabiz23h
EMA approves Roche’s Vabysmo prefilled syringe for three retinal conditions that can cause blindness
EMA approves Roche’s Vabysmo prefilled syringe for three retinal conditions that can cause blindness: Basel Saturday, December 14, 2024, 10:00 Hrs [IST] Roche announced that the ...